Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release
Open Access
- 7 February 2013
- journal article
- Published by Springer Nature in Microbial Cell Factories
- Vol. 12 (1) , 16
Abstract
Background: Adhesins of pathogens recognise the glycans on the host cell and mediate adherence. They are also crucial for determining the tissue preferences of pathogens. Currently, glyco-nanomaterials provide potential tool for antimicrobial therapy. We demonstrate that properly glyco-tailored inclusion bodies can specifically bind pathogen adhesins and release therapeutic substances. Results: In this paper, we describe the preparation of tailored inclusion bodies via the conjugation of indicator protein aggregated to form inclusion bodies with soluble proteins. Whereas the indicator protein represents a remedy, the soluble proteins play a role in pathogen recognition. For conjugation, glutaraldehyde was used as linker. The treatment of conjugates with polar lysine, which was used to inactivate the residual glutaraldehyde, inhibited unwanted hydrophobic interactions between inclusion bodies. The tailored inclusion bodies specifically interacted with the SabA adhesin from Helicobacter pylori aggregated to form inclusion bodies that were bound to the sialic acids decorating the surface of human erythrocytes. We also tested the release of indicator proteins from the inclusion bodies using sortase A and Ssp DNAB intein self-cleaving modules, respectively. Sortase A released proteins in a relatively short period of time, whereas the intein cleavage took several weeks. Conclusions: The tailored inclusion bodies are promising “nanopills” for biomedical applications. They are able to specifically target the pathogen, while a self-cleaving module releases a soluble remedy. Various self-cleaving modules can be enabled to achieve the diverse pace of remedy release.Keywords
This publication has 34 references indexed in Scilit:
- Quantitative Modeling Assesses the Contribution of Bond Strengthening, Rebinding and Force Sharing to the Avidity of Biomolecule InteractionsPLOS ONE, 2012
- Packaging protein drugs as bacterial inclusion bodies for therapeutic applicationsMicrobial Cell Factories, 2012
- Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cellsMicrobial Cell Factories, 2012
- Streamlined protein expression and purification using cleavable self-aggregating tagsMicrobial Cell Factories, 2011
- Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tractGut, 2011
- Carbohydrate engineered cells for regenerative medicine☆Advanced Drug Delivery Reviews, 2010
- Biotinylated-sortase self-cleavage purification (BISOP) method for cell-free produced proteinsBMC Biotechnology, 2010
- Nanomicellar Formulations for Sustained Drug Delivery: Strategies and Underlying PrinciplesNanomedicine, 2010
- Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cellsMicrobial Cell Factories, 2010
- SabA Is the H. pylori Hemagglutinin and Is Polymorphic in Binding to Sialylated GlycansPLOS Pathogens, 2006